Subject(s)
Azacitidine/administration & dosage , Leukemia, Myeloid, Acute/drug therapy , Leukemia, Myeloid, Acute/mortality , Maintenance Chemotherapy , Thalidomide/analogs & derivatives , Aged , Aged, 80 and over , Disease-Free Survival , Female , Humans , Lenalidomide , Male , Middle Aged , Survival Rate , Thalidomide/administration & dosageABSTRACT
In the attempt to harmonize clinical practices between different French transplantation centers, the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC) set up the third annual series of workshops which brought together practitioners from all member centers and took place in October 2012 in Lille. Here we report our results and recommendations regarding the management of short and long-term endocrine dysfunction following allogeneic stem cell transplantation. The key aim of this workshop was to give an overview on secondary adrenal insufficiency and osteoporosis post-transplant.
Subject(s)
Adrenal Insufficiency/therapy , Endocrine System Diseases/etiology , Endocrine System Diseases/therapy , Hematopoietic Stem Cell Transplantation/adverse effects , Osteoporosis/therapy , Adrenal Insufficiency/etiology , Adult , Bone Density , Child , Dietary Supplements , Diphosphonates/therapeutic use , Glucocorticoids/adverse effects , Humans , Immunosuppressive Agents/adverse effects , Osteoporosis/etiology , Transplantation, Homologous , Vitamins/therapeutic useABSTRACT
In the attempt to harmonize clinical practices between different French transplantation centers, the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC) set up the third annual series of workshops which brought together practitioners from all member centers and took place in October 2012 in Lille. Here we report our results and recommendations regarding the management of short and long-term endocrine dysfunction following allogeneic stem cell transplantation. The key aim of this workshop was to give an overview on dyslipidemia and thyroid disorders post-transplant.
Subject(s)
Dyslipidemias/therapy , Endocrine System Diseases/etiology , Endocrine System Diseases/therapy , Hematopoietic Stem Cell Transplantation/adverse effects , Thyroid Diseases/therapy , Choice Behavior , Consensus , Diet , Dyslipidemias/etiology , Fibric Acids/therapeutic use , Hematopoietic Stem Cell Transplantation/standards , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Monitoring, Physiologic/methods , Monitoring, Physiologic/standards , Thyroid Diseases/etiology , Transplantation, HomologousABSTRACT
In the attempt to harmonize clinical practices between different French transplantation centers, the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC) set up the third annual series of workshops which brought together practitioners from all member centers and took place in October 2012 in Lille. Here we report our results and recommendations regarding the management of short and long-term endocrine dysfunction following allogeneic stem cell transplantation. The key aim of this workshop was to give an overview gonadal failure, fertility preservation and post-transplant.
